Trial Profile
A Multiple Rising-Dose Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs FK 788 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 12 Dec 2011 New trial record